Unichem Laboratories informed the bourses on Friday that it has received abbreviated new drug application (ANDA) approval for its Baclofen tablets, USP, 10 mg and 20 mg from United States Food and Drug Administration (USFDA) to market a generic version of Lioresal (Baclofen)